RecruitingNCT07161271

Retrospective Cohort Study of Low-Flow Extracorporeal Carbon Dioxide Removal (ECCO2R) System: Evaluating ECCO2R's Efficacy and Safety in Participants With Respiratory Failure

Retrospective Cohort Study of Low-Flow Extracorporeal Carbon Dioxide Removal (ECCO2R) System: Evaluating Efficacy and Safety

Sponsor

Hong Kong University

Enrollment

59 participants

Start Date

Nov 1, 2024

Study Type

OBSERVATIONAL

Conditions

Respiratory Failure Asthma (Diagnosis)ICU ARDS

Summary

This is an observational study performed by retrospective review of data routinely collected for patients receiving low-flow extracorporeal carbon dioxide removal (ECCO2R) therapy in intensive care units (ICUs). Our aim is to firstly, describe the local practice in terms of patient selection and technical details of clinical management related to the use of low-flow ECCO2R system, and secondly, the clinical results in terms of patient outcomes and adverse events. These findings may allow clinicians to improve the quality and safety of ECCO2R therapy provision in the ICU.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study looks back at medical records of patients who needed help removing carbon dioxide from their blood while on life support in an intensive care unit (ICU). The goal is to understand how well and how safely a device called ECCO2R — a type of lung-support machine — worked in people with serious breathing problems. **You may be eligible if...** - You were treated with an ECCO2R device at one of the participating hospitals - You were admitted to the ICU between January 2022 and June 2024 - You are 18 years of age or older **You may NOT be eligible if...** - You were under 18 years old at the time of treatment Note: Because this study reviews past medical records, there is no active treatment involved. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.